Skip to content

Tla Gut (Uc)

by TLA Targeted Immunotherapies AB Sweden EUDAMED

Ref 00170-SS-bTECKModel TLA GUT UC EMDN B030202,B030299

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-70-SS-bTECKAA Basic UDI-DIDate1 Feb 2024RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 25 Oct 2026

Device Name
Tla Gut
Model / Reference
TLA GUT UC, 00170-SS-bTECK
Primary DI / UDI-DI
D-70-SS-bTECKAA
Basic UDI-DI
B-70-SS-bTECKAA
EMDN Code
B030202,B030299
Device Class
Class IIb
Market of Registration
Sweden

Manufacturer details

EUDAMED SRN
SE-MF-000039975

Properties & raw data

Show properties, registry sources and raw records
Other properties (11)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 69197d9f-73a5-424f-bfb3-a6b73d8705f7 61 fields · synced 25 Oct 2026